ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



Bibliometric landscape of current research on acetoxychavicol acetate

Febri Wulandari, Muhammad Da’i, Ahmad Fauzi, Maryati Maryati, Mahmoud Mirzaei.



Abstract
Download PDF Post

Acetoxychavicol acetate (ACA) is a promising natural compound with an extensive spectrum of medicinal properties. This study aimed to provide bibliometric mapping to evaluate the ACA trends in publishing and original research. We conducted a targeted search on the Scopus database for relevant literature and examined the acquired data using VOSviewer to determine the citation and keyword patterns. A total of 135 articles were examined. Over several years, research on the ACA has revealed a fluctuating pattern. Currently, Japan and Malaysia are the most prolific countries in studies related to ACA, and they also demonstrate the most extensive collaboration networks. Co-occurrence analysis of keywords revealed that anticancer phrases ranked the highest. This study provides a comprehensive overview of the current research landscape and outlines future expectations for the development of ACA as a drug candidate.

Key words: acetoxychavicol acetate (ACA), bibliometric mapping, VOSviewer, pharmacological activity, anticancer







Bibliomed Article Statistics

18
24
31
13
25
10
11
16
20
18
27
4
R
E
A
D
S

11

14

12

10

13

3

9

18

20

16

13

1
D
O
W
N
L
O
A
D
S
050607080910111201020304
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.